open access

Vol 9, No 1 (2007)
Published online: 2007-02-01
Get Citation

The effect of Allopurinol on intestinal ischemia-reperfusion injury development - the new approach

Tomasz Dawiskiba, Artur Pupka, Jan Skóra, Dariusz Janczak, Stanisław Pawłowski, Zbigniew Krawczyk, Przemysław P. Szyber, Piotr Szyber
Chirurgia Polska 2007;9(1):25-33.

open access

Vol 9, No 1 (2007)
Published online: 2007-02-01

Abstract


Background: The aim of the study was to evaluate the effect of Allopurinol on intestinal ischemia-reperfusion injury and xanthine oxidase system.
Material and methods: 70 Buffalo rats were divided into 5 groups of 14. Group I was the control group. The animals of groups II and IV were subjected to 50 minutes of acute intestinal ischemia. The animals of groups III and V were subjected to 50 minutes of acute intestinal ischemia followed by 60 minutes of reperfusion. The rats of group IV and V were pretreated with Allopurinol for three days before surgery. Total intestinal ischemia was produced by clamping the mesenteric vessels. Mucosal changes underwent histopathological evaluation according to the scoring system (0-5) described by Chiu. Biochemical tests of xanthine oxidase activity were performed in supernatants of small intestine homogenates.
Results: The administration of Allopurinol significantly reduced mesenteric ischemia-reperfusion injury as well as intestinal xanthine oxidase activity. However, there was no significant difference in the xanthine oxidase activity between non-pretreated rats subjected to ischemic processes and the control group. It was also noted that beneficial action of Allopurinol began during the ischemic phase, before reperfusion.
Conclusions: It can be concluded that the protective effect of Allopurinol against intestinal ischemiareperfusion is not only related to the reperfusion component. The role of xanthine oxidase in the processes of injury resulting from blood flow disturbances remains a matter of controversy.

Abstract


Background: The aim of the study was to evaluate the effect of Allopurinol on intestinal ischemia-reperfusion injury and xanthine oxidase system.
Material and methods: 70 Buffalo rats were divided into 5 groups of 14. Group I was the control group. The animals of groups II and IV were subjected to 50 minutes of acute intestinal ischemia. The animals of groups III and V were subjected to 50 minutes of acute intestinal ischemia followed by 60 minutes of reperfusion. The rats of group IV and V were pretreated with Allopurinol for three days before surgery. Total intestinal ischemia was produced by clamping the mesenteric vessels. Mucosal changes underwent histopathological evaluation according to the scoring system (0-5) described by Chiu. Biochemical tests of xanthine oxidase activity were performed in supernatants of small intestine homogenates.
Results: The administration of Allopurinol significantly reduced mesenteric ischemia-reperfusion injury as well as intestinal xanthine oxidase activity. However, there was no significant difference in the xanthine oxidase activity between non-pretreated rats subjected to ischemic processes and the control group. It was also noted that beneficial action of Allopurinol began during the ischemic phase, before reperfusion.
Conclusions: It can be concluded that the protective effect of Allopurinol against intestinal ischemiareperfusion is not only related to the reperfusion component. The role of xanthine oxidase in the processes of injury resulting from blood flow disturbances remains a matter of controversy.
Get Citation

Keywords

intestinal ischemia-reperfusion injury; allopurinol; xanthine oxidase

About this article
Title

The effect of Allopurinol on intestinal ischemia-reperfusion injury development - the new approach

Journal

Chirurgia Polska (Polish Surgery)

Issue

Vol 9, No 1 (2007)

Pages

25-33

Published online

2007-02-01

Bibliographic record

Chirurgia Polska 2007;9(1):25-33.

Keywords

intestinal ischemia-reperfusion injury
allopurinol
xanthine oxidase

Authors

Tomasz Dawiskiba
Artur Pupka
Jan Skóra
Dariusz Janczak
Stanisław Pawłowski
Zbigniew Krawczyk
Przemysław P. Szyber
Piotr Szyber

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl